Immunic Inc (IMUX)
1.27
+0.04
(+3.25%)
USD |
NASDAQ |
Apr 30, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Immunic 1 Year Total Returns (Daily): -23.49% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -23.49% |
April 29, 2024 | -25.90% |
April 26, 2024 | -25.15% |
April 25, 2024 | -19.23% |
April 24, 2024 | -18.42% |
April 23, 2024 | -20.51% |
April 22, 2024 | -21.15% |
April 19, 2024 | -28.05% |
April 18, 2024 | -21.60% |
April 17, 2024 | -21.68% |
April 16, 2024 | -10.49% |
April 15, 2024 | -8.39% |
April 12, 2024 | 4.35% |
April 11, 2024 | -2.78% |
April 10, 2024 | 4.51% |
April 09, 2024 | -7.19% |
April 08, 2024 | -7.19% |
April 05, 2024 | -17.42% |
April 04, 2024 | -15.75% |
April 03, 2024 | -24.22% |
April 02, 2024 | -18.12% |
April 01, 2024 | -8.72% |
March 28, 2024 | -9.59% |
March 27, 2024 | -15.03% |
March 26, 2024 | -13.51% |
Date | Value |
---|---|
March 25, 2024 | -12.16% |
March 22, 2024 | -16.46% |
March 21, 2024 | -20.71% |
March 20, 2024 | -17.37% |
March 19, 2024 | -20.00% |
March 18, 2024 | -20.61% |
March 15, 2024 | -20.12% |
March 14, 2024 | -26.14% |
March 13, 2024 | -20.83% |
March 12, 2024 | -18.07% |
March 11, 2024 | -13.86% |
March 08, 2024 | -29.49% |
March 07, 2024 | -37.07% |
March 06, 2024 | -34.08% |
March 05, 2024 | -22.28% |
March 04, 2024 | -20.73% |
March 01, 2024 | -26.77% |
February 29, 2024 | -26.01% |
February 28, 2024 | -29.29% |
February 27, 2024 | -26.46% |
February 26, 2024 | -32.28% |
February 23, 2024 | -38.07% |
February 22, 2024 | -35.45% |
February 21, 2024 | -33.33% |
February 20, 2024 | -32.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.82%
Minimum
Jul 10 2019
282.2%
Maximum
Mar 16 2021
-22.32%
Average
-37.41%
Median
Dec 31 2021
1 Year Total Returns (Daily) Benchmarks
Kymera Therapeutics Inc | 6.56% |
Insmed Inc | 26.72% |
SELLAS Life Sciences Group Inc | -11.74% |
Skye Bioscience Inc | 288.9% |
Leap Therapeutics Inc | -21.29% |